Zobrazeno 1 - 10
of 38
pro vyhledávání: '"Ahmad Nakshabandi"'
Autor:
Rahman Nakshabendi, Andrew C. Berry, Daisy Torres-Miranda, Francis Daniel LaBarbera, Ozdemir Kanar, Ahmad Nakshabandi, Imad Nakshabendi
Publikováno v:
Case Reports in Gastrointestinal Medicine, Vol 2016 (2016)
In immunocompromised patients, histoplasmosis may present as disseminated disease. We present a 52-year-old Caucasian male with symptoms of dyspepsia, postprandial epigastric pain, nausea, and nonbloody diarrhea. Upper and lower gastrointestinal endo
Externí odkaz:
https://doaj.org/article/bddaa8255cfa4389a0f4da849c9ddbc3
Publikováno v:
Clinics in Liver Disease. 26:13-19
Endoscopic mucosal resection and dissection are advanced endoscopic procedures that have proven essential for resecting premalignant and early malignant lesions throughout the gastrointestinal tract. Over time, these procedures have proven to play a
Autor:
Stephanie M. Woo, Mark J. Real, Brett M. Will, Eric J. Kim, Jiling Chou, Ahmed A. Alsaiari, Ahmad Nakshabandi, Walid M. Chalhoub, Nadim G. Haddad
Publikováno v:
Translational Gastroenterology and Hepatology. 8:15-15
Autor:
Cynthia Liu, Fredy Nehme, Daniel J. Low, Faisal S. Ali, Abraham Yu, Ahmad Nakshabandi, Phillip Lum, Brian R. Weston, Emmanuel Coronel, Phillip S. Ge, William A. Ross, Jeffrey Lee
Publikováno v:
Gastrointestinal Endoscopy. 95:AB482-AB483
Autor:
Fredy Nehme, Brian R. Weston, Phillip S. Ge, William A. Ross, Abraham Yu, Cynthia Liu, Daniel J. Low, Emmanuel Coronel, Ahmad Nakshabandi, Phillip Lum, Faisal S. Ali, Jeffrey Lee
Publikováno v:
Gastrointestinal Endoscopy. 95:AB514-AB515
Autor:
Fredy Nehme, Cynthia Liu, Phillip S. Ge, Emmanuel Coronel, William A. Ross, Brian R. Weston, Faisal S. Ali, Daniel J. Low, Abraham Yu, Ahmad Nakshabandi, Phillip Lum, Jeffrey Lee
Publikováno v:
Gastrointestinal Endoscopy. 95:AB500-AB501
Publikováno v:
American Journal of Gastroenterology. 117:e264-e264
Autor:
Rohan Mandaliya, Mark Mattar, Aline Charabaty, Anita Sivaraman, Alexander E Dao, Sandeep Nadella, Ahmad Nakshabandi, Angela Hsu
Publikováno v:
World Journal of Gastrointestinal Endoscopy
Background Capecitabine is considered a first line agent in adjuvant therapy for breast and colorectal cancer. However, cases of severe diarrhea have been reported with increasing frequency in recent years. When diarrhea is severe and prolonged, cape
Publikováno v:
Expert Opinion on Drug Metabolism & Toxicology. 15:231-244
Immune checkpoint inhibitors (ICIs) block cytotoxic T lymphocyte antigen 4 (CTLA-4) and programmed cell death protein 1 (PD-1)/PD ligand 1 (PD-L1) receptors that control antitumor activities of lymphocytes. While highly efficacious, these drugs have
Autor:
Fredy Nehme, Jeffrey Lee, Emmanuel Coronel, Phillip S. Ge, William A. Ross, Cynthia Liu, Daniel J. Low, Abraham Yu, Ahmad Nakshabandi, Faisal S. Ali, Martin Coronel, Phillip Lum, Brian R. Weston
Publikováno v:
Gastrointestinal Endoscopy. 95:AB540